Nitrofurantoin Tillomed Laboratories (Nitrofurantoin)

Nitrofurantoin inhibits the bacterial enzyme pyruvate flavodoxin oxidoreductase, disrupting carbohydrate metabolism and energy production in susceptible bacteria. This metabolic interference leads to bacterial cell death, especially in the urinary tract where the drug achieves high concentrations.

The dosage of Nitrofurantoin Tillomed is determined by the prescribing clinician based on the patient’s condition, renal function, and local treatment guidelines. Only a qualified healthcare professional should set the appropriate dose and treatment duration.

The safety of nitrofurantoin in pregnancy is not fully established; it is generally avoided in the first trimester and near term unless the benefit outweighs the risk. While breastfeeding, caution is advised and the infant should be monitored for possible adverse effects.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nitrofurantoin is distinct from other urinary antiseptics such as trimethoprim‑sulfamethoxazole or fluoroquinolones because it concentrates primarily in urine and has a unique mechanism targeting bacterial metabolism. It is often preferred for uncomplicated infections due to its narrow spectrum and low resistance rates, though individual patient factors dictate the best choice.

Nitrofurantoin Tillomed should be stored at temperatures below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed to maintain stability.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their healthcare professional to optimize absorption and minimize gastrointestinal upset.

Serious risks include pulmonary toxicity, which can manifest as interstitial lung disease, severe liver injury, hemolytic anemia in individuals with G6PD deficiency, and rare but severe allergic reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience respiratory symptoms, jaundice, or severe skin reactions.

Nitrofurantoin is contraindicated in patients with severe renal impairment (creatinine clearance <30 mL/min), known hypersensitivity to nitrofurantoin, or G6PD deficiency due to the risk of hemolysis. Caution is also advised for pregnant women near term and breastfeeding mothers.